Daily as of 3 Nov 16:00 ET
- Price
- above both $45.33 vs 50 $42.19 / 200 $44.31
- Projection
- No cross projected
- Test
- No active test
- Last cross
- ๐Death cross 28 May 2025 ยท projected 21 bars out
Sanofi (SNY) is a NASDAQ-listed ADR that Cruxta has tracked for 50/200 crosses since 2017.
The 50 SMA has sat below the 200 on the daily since May 2025, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits above the 50 and the 200; on the weekly it is below both.
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 28 Sep 2026 | ๐Death | 4-hour | 25 bars out | Not tested |
| 31 Aug 2026 | ๐จGolden | 4-hour | 30 bars out | 4 bar cross test |
| 5 May 2026 | ๐Death | 4-hour | 10 bars out | Not tested |
| 29 Apr 2026 | ๐จGolden | 4-hour | 22 bars out | 1 bar cross test |
| week of 16 Feb 2026 | ๐Death flat | weekly | 18 bars out | 1 bar cross test |
Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.